About

Context belongs beside the number.

People comparing programs often encounter a price before they encounter the details needed to interpret it. Slow Ledger 49 exists to keep those details visible: what may be included, what questions remain open, and why a lower or higher figure cannot speak for safety by itself.

Our starting point is the same practical question that guides the cost comparison resource: how can someone examine information without mistaking a claim for a conclusion? We organize material so readers can pause, compare, and identify the limits of what is known.

“A useful resource makes room for both the question and the uncertainty around it.”

Evidence first, with the limits named.

We look to registries, published literature, official sources, and direct program materials where appropriate. When evaluating health-related information, we treat primary research and established reference sources as more useful starting points than promotional summaries; the National Library of Medicine’s guidance on research reporting reflects why clear sourcing and attribution matter.

We also distinguish legal or regulatory information from advice. The FDA’s public drug data resources illustrate the value of checking official records directly rather than relying on simplified claims. Sources can change, evidence can be incomplete, and no overview replaces individualized professional assessment.

What guides each page.

Slow Ledger 49 is for people comparing program information and looking for clearer context on safety, legality, included care, and cost. We aim to make the review process more legible without pretending that a website can settle personal decisions.

• Independence over promotional framing
• Plain language over unnecessary certainty
• Safety context alongside financial comparisons
• Cost clarity without false precision
• Evidence awareness with limitations stated

Readers seeking region-specific context may encounter information about ibogaine in Canada, accounts of an ibogaine trip experience, or explanations of how ibogaine is administered. These materials should be approached as information to evaluate, not as a substitute for qualified care.

We encourage readers to check the specificity of claims about ibogaine centers in Mexico, descriptions of an ibogaine Mexico clinic, and assertions about whether ibogaine works for alcohol. The evidence-based medicine framework is a useful reminder that individual claims need to be considered alongside evidence quality, expertise, and individual circumstances.